Improving effects of aminoguanidine on the histologic alterations in rat kidneys in diabetes;Diyabetin böbreklerde neden olduǧu histolojik deǧişiklikler üzerine aminoguanidinin i̇yileş tirici etkileri

Turkiye Klinikleri Journal of Medical Sciences

Volumn 26, Issue 6, 2006, Pages 599-606

  Vardi, Nigar ^a   Iraz, Mustafa ^a   Gül, Mehmet ^a   Öztürk, Feral ^a   Uçar, Muharrem ^b   Otlu, Ali ^a  

^a INONU UNIVERSITY   (Turkey)

^b Erzurum Numune Hastanesi   (Turkey)

Author keywords

Diabetes mellitus; Experimental; Histology; Kidney; Pimagedine

Indexed keywords

AMINOGUANIDINE; GLUCOSE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EPITHELIUM CELL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

EID: 33846007697     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Crawford JM, Cotran RS. The pancreas. In: Cotran RS, Kumar V, Collins T, eds. Pathologic Basis of Disease. USA: WB Saunders Company; 1999. p.913-20.
2. Liptakova A, Carsky J, Ulicna O, Vancova O, Bazek P, Durackova Z. Influence of β-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus. Physiol Res 2002;51:277-84.
3. Agardh CD, Stenram U, Torffvit O, Agardh E. Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complications 2002;16:395-400.
4. Lehmann R, Schleicher ED. Molecular mechanism of diabetic nephropathy. Clin Chim Acta 2000;297:135-44.
5. +- ATPase in rats. Pharmacol Res 2001;44:95-8.
6. Ihm SH, Yoo HJ, Park SW, Ihm J. Effect of aminoguanidine on lipid peroxidation in streptozotocin induced diabetic rats. Metabolism 1999;48:1141-5.
7. Osicka TM, Kiriazis Z, Pratt LM, Jerums G, Comper WD. Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia 2001;44:230-6.
8. Vardi N, Iraz M, Öztürk F, Uçar M, Gül, M Eşrefoǧlu M ve Otlu A. Deneysel diyabetin siçan böbreklerinde meydana getirdiǧi histolojik deǧiş iklikler üzerine melatoninin iyileştirici etkileri. İnönü Üniversitesi Tip Fakültesi Dergisi 2005;12:145-52.
9. Rao VS, Santos FA, Silva RM, Teixiera MG. Effects of nitric oxide synthase inhibitors and melatonin on the hyperglycemic responce to streptozotocin in rats. Vascul Pharmacol 2002;38:127-30.
10. Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 1995;56:1789-98.
11. Tanaka Y, Shimizu H, Sato N, Mori M, Shimomura Y. Involvement of spontaneous nitric oxide production in the diabetogenic action of streptozotocin. Pharmacology 1995;50:69-73.
12. Haluzik M, Nedvidkova J, Skrha J. The influence of NO synthase inhibitor and free oxygen radicals scavenger, methylene blue on streptozotocin- induced diabetes in rats. Physiol Res 1998;47:337-41.
13. Cam M, Yavuz O, Guven A, Ercan F, Bukan N, Ustundag N. Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res 2003;35:212-20.
14. Yakan B, Eşrefoǧlu M. Deneysel diabetes mellitusda böbreklerin ince yapisi ve selenyumunun düzeltici etkileri. Turkiye Klinikleri J Med Sci 1995;15:255-9.
15. Gugliucci A. Glycation as the glucose link to diabetic complications. J Am Osteopath Assoc 2000;100: 621-34.
16. Teschner M, Schaefer RM, Svarnas A, Heidland U, Heidland A. Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats. Am J Nephrol 1989;9:464-9.
17. Nilsson BO. Biological effects of aminoguanidine: An update. Inflamm Res 1999;48:509-15.
18. Giardino I, Fard AK, Hatchell DL, Browlee M. Amino-guanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 1998;47:1114-20.
19. nd, Kreisberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990;136:1339-48.
20. Suzuki D, Miyata T, Saotome N, et al. Immunohistochemical evidence for an increased oxidative stres and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 1999;10:822-32.
21. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003;14:241-5.
22. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000;43:1205-23.
23. Reeves WB, Andreoli TE. Transforming growth factor β contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 2000;97:7667-9.
24. Ha H, Kim KH. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase. Diabetes Res Clin Pract 1999;45:147-51.
25. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 1991;40:1328-34